-
-
-
-
-
-
-
Myriad Genetics provides 2025 preliminary results and 2026 guidance
-
-
-
-
-
-
-
Myriad Genetics (MYGN) call put ratio 6.2 calls to 1 put with a focus on August 7 and February 5 calls
-
-
-
-
-
-
-
Myriad Genetics (MYGN) Appoints Brian Donnelly as Chief Commercial Officer
-
-
-
-
-
-
-
Myriad Genetics (MYGN) Announces Senior Leadership Transition
-
-
-
-
-
-
-
UBS Starts Myriad Genetics (MYGN) at Neutral
-
-
-
-
-
-
-
Myriad Genetics (MYGN) and jscreen Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access
-
-
-
-
-
-
-
Myriad Genetics (MYGN) Announces Five Research Collaborations to Study the Use of MRD Testing in Breast Cancer
-
416,803 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

